AXIM Biotechnologies, Inc. (AXIM)
OTCMKTS · Delayed Price · Currency is USD
0.0070
+0.0010 (16.28%)
Jul 2, 2025, 4:00 PM EDT

AXIM Biotechnologies Company Description

AXIM Biotechnologies, Inc. develops diagnostic healthcare solutions for ophthalmological conditions.

It develops and commercializes two point-of-care diagnostic tests to assist eye-care physicians in detecting and quantifying biomarkers associated with aqueous deficient dry eye disease and non-specific allergic conjunctivitis, including ocular total immunoglobulin E allergy test and lactoferrin ADDE test.

It also operates a full-service center for custom biomarker and biopharmaceutical research, custom assay development, clinical sample testing, and precision data delivery.

In addition, the company develops a line of novel diagnostics for early cancer detection, response to treatment, and recurrence monitoring, as well as COVID-19 rapid diagnostic tools.

The company was formerly known as Axim International Inc. and changed its name to AXIM Biotechnologies, Inc. in July 2014.

AXIM Biotechnologies, Inc. was incorporated in 2010 and is based in San Diego, California.

AXIM Biotechnologies, Inc.
AXIM Biotechnologies logo
Country United States
Founded 2010
Industry Biotechnology
Sector Healthcare
Employees 7
CEO Catalina Valencia

Contact Details

Address:
6191 Cornerstone Court, East
San Diego, Nevada 92121
United States
Phone 858 923 4422
Website aximbiotech.com

Stock Details

Ticker Symbol AXIM
Exchange OTCMKTS
Fiscal Year January - December
Reporting Currency USD
ISIN Number US05463V1008
SIC Code 2835

Key Executives

Name Position
Catalina Valencia J.D. Chief Executive Officer, President and Director
Robert T. Malasek Chief Financial Officer and Secretary
Kurt Phinney Chief Operating Officer
Dr. Sergei A. Svarovsky M.B.A., Ph.D. Chief Scientific Officer
Dr. Douglas Lake Ph.D. Chief Clinical Officer of Sapphire Biotech, Inc.
Dr. Alim Seit-Nebi Ph.D. Chief Technology Officer and Co-Founder of Sapphire Biotech, Inc.
Jeffrey A. Busby Senior Vice President of Business Development
Dr. Joseph Tauber M.D. Chief Medical Officer and Chairman of the Medical Advisory Board
Dr. Maria J. Gonzalez Moa Ph.D. Vice President of Product Development - Sapphire Biotech, Inc.